← back to search

Yisheng Li

The University of Texas MD Anderson Cancer Center · US
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Cancer survivorship and care, Genetic factors in colorectal cancer, Smoking Behavior and Cessation, and Behavioral Health and Interventions.
h-index
48
citations
8,276
works
370
NIH funding
primary concept
Medicine
email

Recent publications

Analysis of Breast Cancer Mortality in the US—1975 to 2019
JAMA 2024cited by 261position: middledoi
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies
JAMA 2024cited by 51position: middledoi
Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials
Journal of Immunotherapy and Precision Oncology 2023cited by 19position: middledoi
Efficacy of a Smoking Cessation Intervention for Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer: A Randomized Controlled Trial
Journal of Clinical Oncology 2023cited by 15position: middledoi
Medication-Related Osteonecrosis of the Jaw in Patients Treated Concurrently with Antiresorptive and Antiangiogenic Agents: Systematic Review and Meta-Analysis
Journal of Immunotherapy and Precision Oncology 2021cited by 18position: middledoi
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Breast Cancer Research 2020cited by 145position: middledoi
Feasibility and efficacy of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy: a randomized controlled pilot study
Supportive Care in Cancer 2020cited by 25position: middledoi
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation
Breast Cancer Research 2019cited by 227position: middledoi
Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012
JAMA 2018cited by 300position: middledoi
Enhancing Smoking Risk Communications: The Influence of Health Literacy and Message Content
Annals of Behavioral Medicine 2018cited by 35position: middledoi
HIV Care Initiation: A Teachable Moment for Smoking Cessation?
Nicotine & Tobacco Research 2017cited by 25position: middledoi
Comparison of Internet and Telephone Interventions for Weight Loss Among Cancer Survivors: Randomized Controlled Trial and Feasibility Study
JMIR Cancer 2017cited by 18position: middledoi
Combined treatment for at-risk drinking and smoking cessation among Puerto Ricans: A randomized clinical trial
Addictive Behaviors 2016cited by 30position: middledoi
Psychological stress and short-term hospitalisations or death in patients with heart failure
Heart 2016cited by 28position: middledoi
Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide-3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
Journal of Clinical Oncology 2014cited by 177position: middledoi
Gastroprotective and anti-Helicobacter pylori potential of herbal formula HZJW: safety and efficacy assessment
BMC Complementary and Alternative Medicine 2013cited by 25position: middledoi
Sweet tea leaves extract improves leptin resistance in diet-induced obese rats
Journal of Ethnopharmacology 2012cited by 54position: middledoi
SU2C phase Ib study of pan-PI3K inhibitor BKM120 with letrozole in ER+/HER2- metastatic breast cancer (MBC).
Journal of Clinical Oncology 2012cited by 22position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew J. Waters · University of Kansas3 papers (2016–2018)Damon J. Vidrine · University of Oklahoma Health Sciences Center3 papers (2017–2023)Carlos L. Arteaga · Southwestern Medical Center3 papers (2012–2020)Eric P. Winer · Yale University3 papers (2012–2020)Justin M. Balko · John Wiley & Sons (United States)2 papers (2012–2014)Xiao‐Ping Lai · Guangzhou University of Chinese Medicine2 papers (2012–2013)María G. Kuba · Tennessee Oncology2 papers (2012–2014) · 2 papers (2017–2020)Jaejoon Song · The University of Texas Health Science Center at Houston2 papers (2017–2020)Natasha K. Stout · National Cancer Institute2 papers (2018–2024)Steven J. Isakoff · Harvard University2 papers (2012–2014)Amy Trentham‐Dietz · University of Wisconsin–Madison2 papers (2018–2024)Graciela M. Nogueras‐González · The University of Texas MD Anderson Cancer Center2 papers (2021–2023)Jeffrey T. Yap · University of Utah2 papers (2012–2014)Jeanne S. Mandelblatt · Georgetown University2 papers (2018–2024)Karen Basen‐Engquist · University of Alabama at Birmingham2 papers (2017–2020)Sylvia K. Plevritis · Stanford University2 papers (2018–2024)Oğuzhan Alagöz · University of Wisconsin System2 papers (2018–2024)Juhee Song · The University of Texas MD Anderson Cancer Center2 papers (2018–2024)Sandra J. Lee · Georgetown University Medical Center2 papers (2018–2024)